Princeton-based Agile Therapeutics Inc., a women’s health specialty pharmaceutical company, announced Thursday that it has priced its initial public offering.
According to the announcement, 9.16 million share of its common stock will be priced to the public at $6.00 per share. Agile has granted underwriters a 30-day option to purchase up to an additional 1.375 million additional shares to cover any over-allotments.
The shares are expected to begin trading on the NASDAQ on May 23, 2014 under the symbol “AGRX.” The offering should close on May 29, 2014, the announcement said.
Bookrunning managers for the offering are RBC Capital Markets LLC and William Blair & Co. LLC. Also, Cantor Fitzgerald & Co. and Janney Montgomery Scott LLC are co-managers.
ALSO ON NJBIZ:
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy